Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

Antengene and Its Partners Publish Preclinical Data Demonstrating the Encouraging Activity of Selinexor in the Prevention and Treatment of SARS-CoV-2 Infections

prnasiaJuly 26, 2021

Tag: Antengene , Selinexor , SARS-CoV-2 , Xpo1

PharmaSources Customer Service